75 related articles for article (PubMed ID: 15155017)
1. New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions.
Kent DM; Fendrick AM; Langa KM
Med Decis Making; 2004; 24(3):281-6. PubMed ID: 15155017
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness as an outcome in randomized clinical trials.
Hlatky MA; Owens DK; Sanders GD
Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis and innovation.
Jena AB; Philipson TJ
J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
[TBL] [Abstract][Full Text] [Related]
6. Big ticket health technology: is rational utilization possible?
Johansen KS; Racoveanu NT
Med Prog Technol; 1991; 17(2):85-91. PubMed ID: 1835754
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
10. Health technology assessment in oral health.
Esfandiari S; Feine J
Int J Oral Maxillofac Implants; 2011; 26 Suppl():93-100; discussion 101-2. PubMed ID: 21465002
[TBL] [Abstract][Full Text] [Related]
11. The costs and cost-effectiveness of an integrated sepsis treatment protocol.
Talmor D; Greenberg D; Howell MD; Lisbon A; Novack V; Shapiro N
Crit Care Med; 2008 Apr; 36(4):1168-74. PubMed ID: 18379243
[TBL] [Abstract][Full Text] [Related]
12. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
Wallner PE; Konski A
J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of innovative technologies in health care should include a short-run perspective.
Adang EM
Eur J Health Econ; 2008 Nov; 9(4):381-4. PubMed ID: 18188622
[TBL] [Abstract][Full Text] [Related]
14. Health care technology adoption and diffusion in a social context.
Coyte PC; Holmes D
Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
[TBL] [Abstract][Full Text] [Related]
15. Role of emerging technology in the era of cost containment.
Soetikno R; Young HS; Keeffe EB
Gastrointest Endosc Clin N Am; 1997 Apr; 7(2):331-9. PubMed ID: 9101270
[TBL] [Abstract][Full Text] [Related]
16. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
17. A framework for clinical evaluation of diagnostic technologies.
Guyatt GH; Tugwell PX; Feeny DH; Haynes RB; Drummond M
CMAJ; 1986 Mar; 134(6):587-94. PubMed ID: 3512062
[TBL] [Abstract][Full Text] [Related]
18. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
Philipson TJ; Jena AB
AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
[No Abstract] [Full Text] [Related]
19. [Conditions for introduction and financing of new technologies].
Rutten FF; Grijseels EW
Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2229-32. PubMed ID: 10578419
[TBL] [Abstract][Full Text] [Related]
20. Financial managers' costing expertise is needed in clinical trials.
West DA; Balas EA; West TD
J Health Care Finance; 2000; 27(1):11-20. PubMed ID: 10961828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
